Sugi Predict

Sugi Predict / Compounds / SCHEMBL888210

SCHEMBL888210

SCHEMBL888210

NCCCc1cn([C@@H]2CC(O)[C@H](CO)O2)c(=O)[nH]c1=O

nearest known ligand 0.76

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ TK1 P04183 3/20 0.76
▸ TK2 O00142 1/20 0.76
▸ LMNA P02545 2/20 0.68
▸ SMN1; SMN2 Q16637 2/20 0.68
▸ ALOX12 P18054 1/20 0.61
▸ ADRA1A P35348 1/20 0.61
▸ CYP1A2 P05177 1/20 0.59
▸ CYP3A4 P08684 1/20 0.59
▸ TSHR P16473 1/20 0.59
▸ BLM P54132 1/20 0.59
▸ PMP22 Q01453 1/20 0.59
▸ NPSR1 Q6W5P4 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL532244 1.00 TK1 (0.76) TK1TK2LMNASMN1; SMN2ALOX12
SCHEMBL6733504 0.97 TK1 (0.74) TK1TK2LMNASMN1; SMN2ALOX12
SCHEMBL6733500 0.97 TK1 (0.74) TK1TK2LMNASMN1; SMN2ALOX12
SCHEMBL4205795 0.96 TK1 (0.73) TK1TK2LMNASMN1; SMN2ALOX12
SCHEMBL8165631 0.96 TK1 (0.73) TK1TK2LMNASMN1; SMN2ALOX12
SCHEMBL8165629 0.96 TK1 (0.73) TK1TK2LMNASMN1; SMN2ALOX12
SCHEMBL31490225 0.93 TK1 (0.79) TK1TK2LMNASMN1; SMN2ALOX12
SCHEMBL17456218 0.90 TK1 (0.78) TK1TK2LMNASMN1; SMN2ALOX12
SCHEMBL17456217 0.90 TK1 (0.78) TK1TK2LMNASMN1; SMN2ALOX12
SCHEMBL7875550 0.90 TK1 (0.68) TK1TK2LMNASMN1; SMN2ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8465921-B2 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders ELITECH HOLDING B.V. (NL) 2013-06-18 — — US disclosed
US-20110275070-A1 HYBRIDIZATION AND MISMATCH DISCRIMINATION USING OLIGONUCLEOTIDES CONJUGATED TO MINOR GROOVE BINDERS EPOCH PHARMACEUTICALS, INC. 2011-11-10 — — US disclosed
US-7794945-B2 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders ELITECH HOLDING B.V. (NL) 2010-09-14 — — US disclosed
US-7556923-B1 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders EPOCH BIOSCIENCES, INC. (US) 2009-07-07 — — US disclosed
US-20090048427-A1 HYBRIDIZATION AND MISMATCH DISCRIMINATION USING OLIGONUCLEOTIDES CONJUGATED TO MINOR GROOVE BINDERS EPOCH BIOSCIENCES, INC. (US) 2009-02-19 — — US disclosed
EP-0819133-B1 COVALENTLY LINKED OLIGONUCLEOTIDE MINOR GROOVE BINDER CONJUGATES EPOCH BIOSCIENCES INC (US) 2008-01-02 — — EP disclosed
US-20070232798-A1 Process For The Synthesis Of 2'-O-Substituted Pyrimidines And Oligomeric Compounds Therefrom COOK PHILLIP D 2007-10-04 — — US disclosed
EP-0813539-B1 IMPROVED PROCESS FOR THE SYNTHESIS OF 2'-O-SUBSTITUTED PYRIMIDINES AND OLIGOMERIC COMPOUNDS THEREFROM ISIS PHARMACEUTICALS INC (US) 2006-05-24 — — EP disclosed
US-6884584-B2 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders EPOCH BIOSCIENCES, INC. (US) 2005-04-26 — — US disclosed
US-20050064463-A1 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders DRUG ROYALTY LP1 (CA) 2005-03-24 — — US disclosed
WO-1996040711-A1 CROSS-LINKING OLIGONUCLEOTIDES MICROPROBE CORPORATION (US) 1996-12-19 — — WO disclosed
WO-1996032496-A2 COVALENTLY LINKED OLIGONUCLEOTIDE MINOR GROOVE BINDER CONJUGATES MICROPROBE CORPORATION (US) 1996-10-17 — — WO disclosed
EP-0661979-A4 CROSS-LINKING OLIGONUCLEOTIDES FOR ENZYME-MEDIATED TRIPLE STRAND FORMATION. MICROPROBE CORP (US) 1995-09-13 — — EP disclosed
EP-0661979-A1 CROSS-LINKING OLIGONUCLEOTIDES FOR ENZYME-MEDIATED TRIPLE STRAND FORMATION MICROPROBE CORPORATION (US) 1995-07-12 — — EP disclosed
US-5419966-A Solid support for synthesis of 3'-tailed oligonucleotides MICROPROBE CORPORATION (US) 1995-05-30 — — US disclosed
WO-1994001445-A1 BASE-PROTECTED NUCLEOTIDE ANALOGS WITH PROTECTED THIOL GROUPS RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1994-01-20 — — WO disclosed
WO-1993003736-A1 CROSS-LINKING OLIGONUCLEOTIDES FOR ENZYME-MEDIATED TRIPLE STRAND FORMATION MICROPROBE CORPORATION (US) 1993-03-04 — — WO disclosed
EP-0472648-A4 CROSSLINKING OLIGONUCLEOTIDES — 1992-09-16 — — EP disclosed
EP-0472648-A1 CROSSLINKING OLIGONUCLEOTIDES MICROPROBE CORPORATION (US) 1992-03-04 — — EP disclosed
WO-1990014353-A1 CROSSLINKING OLIGONUCLEOTIDES MICROPROBE CORPORATION (US) 1990-11-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050064463-A1 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders DDB1, LIG3, MSH2 TK1 1476/4885TK2 2341/4885LMNA 3853/4885
US-20090048427-A1 HYBRIDIZATION AND MISMATCH DISCRIMINATION USING OLIGONUCLEOTIDES CONJUGATED TO MINOR GROOVE BINDERS DDB1, LIG3, MSH2 TK1 1476/4885TK2 2341/4885LMNA 3853/4885
US-20070232798-A1 Process For The Synthesis Of 2'-O-Substituted Pyrimidines And Oligomeric Compounds Therefrom TYMS, RRM2, ATIC TK1 58/4885TK2 39/4885LMNA 3653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.